NASDAQ:RPRX | Cash Flow Statement | Royalty Pharma plc

Complete source-backed cash-flow history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$17.88M
2026-03-31$294.69M$718.23M-$477.87M$50.1M-$272.67M
2025-12-31$214.21M$827.15M-$847.8M$80.54M-$299.6M
2025-09-30$288.22M
2025-06-30$32.18M
2025-03-31$239.35M$596.08M$503.92M$708.78M-$941.3M
2024-12-31$208.21M$742.53M-$505.59M$52.61M-$257.96M
2024-09-30$543.99M
2024-06-30$102M
2024-03-31$4.78M$664.64M-$86.65M$0.00-$212M
2023-12-31$494.34M$772.63M-$1B$30.2M-$231.89M
2023-09-30$72.11M
2023-06-30$227.63M
2023-03-31$340.76M$1.03B-$558.53M-$210.37M
2022-12-31-$456.08M$569.93M$414.74M$0.00-$265.55M
2022-09-30$142.65M
2022-06-30$304.5M
2022-03-31$51.76M$460.27M$11.17M-$220.97M
2021-12-31$7.9M$489.96M-$551.65M-$198.07M
2021-09-30$101.93M
2021-06-30$440.78M
2021-03-31$69.12M$526.1M-$599.3M-$226.67M
2020-12-31$171.09M$565.67M-$832.4M$0.00-$277.39M
2020-09-30$290.63M
2020-06-30$442.07M
2020-06-17$515.79M
2020-03-31$71.24M$471.1M-$761.75M$542.52M
2019-12-31$1.42B$478.43M-$62.82M$38,000.00-$285.8M
2019-09-30$408.98M
2019-06-30$151.71M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$770.95M$2.49B-$1.61B$1.23B-$1.19B
2024-12-31$858.98M$2.77B-$2.68B$229.65M$361.15M
2023-12-31$1.13B$2.99B-$2.07B$304.76M-$2.15B
2022-12-31$42.83M$2.14B-$1.03B$0.00-$944.86M
2021-12-31$619.73M$2.02B-$1.87B$0.00$385.11M
2020-12-31$975.04M$2.03B-$2.76B$0.00$1.49B
2019-12-31$2.35B$1.67B-$2.15B$4.27M-$1.19B
2018-12-31$1.38B$1.62B$303.42M$0.00-$1.38B

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.